Impact of COVID-19 on pregnant women in South Korea: Focusing on prevalence, severity, and clinical outcomes

[1]  S. Unlu,et al.  Management of pregnant women with COVID‐19: A tertiary pandemic center experience on 1416 cases , 2021, Journal of medical virology.

[2]  M. Hernán,et al.  Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy , 2021, Nature Medicine.

[3]  M. Gorfine,et al.  Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women. , 2021, JAMA.

[4]  F. Malone,et al.  Maternal outcomes and risk factors for COVID-19 severity among pregnant women , 2021, Scientific Reports.

[5]  Jean Y. Ko,et al.  Adverse pregnancy outcomes, maternal complications, and severe illness among U.S. delivery hospitalizations with and without a COVID-19 diagnosis , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  A. Helguera-Repetto,et al.  Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City , 2021, Journal of Maternal-Fetal & Neonatal Medicine.

[7]  Shiliang Liu,et al.  The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis , 2021, Canadian Medical Association Journal.

[8]  M. Dehghan,et al.  The Impact of COVID-19 Outbreak on Nosocomial Infection Rate: A Case of Iran , 2021, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[9]  Jianghui Cai,et al.  Cesarean Section or Vaginal Delivery to Prevent Possible Vertical Transmission From a Pregnant Mother Confirmed With COVID-19 to a Neonate: A Systematic Review , 2021, Frontiers in Medicine.

[10]  Jasmine Rah,et al.  Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients , 2021, American Journal of Obstetrics and Gynecology.

[11]  S. Rasmussen,et al.  Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021. , 2021, JAMA.

[12]  H. Jung,et al.  Power of universal health coverage in the era of COVID-19: A nationwide observational study , 2021, The Lancet Regional Health - Western Pacific.

[13]  F. Figueras,et al.  Pregnant women with SARS‐CoV‐2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx) , 2020, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[14]  E. Olsen,et al.  Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[15]  A. Zhao,et al.  The associated factors of cesarean section during COVID-19 pandemic: a cross-sectional study in nine cities of China , 2020, Environmental Health and Preventive Medicine.

[16]  L. Mofenson,et al.  Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis , 2020, BMJ.

[17]  J. Thachil,et al.  COVID‐19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry—Communication from the ISTH SSC for Women’s Health , 2020, Journal of Thrombosis and Haemostasis.

[18]  Huanhuan Liu,et al.  Clinico-Radiological Features and Outcomes in Pregnant Women with COVID-19 Pneumonia Compared with Age-Matched Non-Pregnant Women , 2020, Infection and drug resistance.

[19]  D. Katsaros,et al.  The “scar” of a pandemic: Cumulative incidence of COVID‐19 during the first trimester of pregnancy , 2020, Journal of medical virology.

[20]  H. Qi,et al.  Changes in physiology and immune system during pregnancy and coronavirus infection: A review , 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology.

[21]  Arthur L. Allen,et al.  Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum , 2020, Journal of Thrombosis and Thrombolysis.

[22]  Reem A Mustafa,et al.  Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  Kehu Yang,et al.  Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis , 2020, medRxiv.

[24]  G. Pilu,et al.  Coronavirus disease 2019 during pregnancy: a systematic review of reported cases , 2020, American Journal of Obstetrics and Gynecology.

[25]  J. Qiao,et al.  Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China , 2020, The New England journal of medicine.

[26]  Dena Goffman,et al.  Universal Screening for SARS-CoV-2 in Women Admitted for Delivery , 2020, The New England journal of medicine.

[27]  B. Na,et al.  Seventy-two Hours, Targeting Time from First COVID-19 Symptom Onset to Hospitalization , 2020, Journal of Korean medical science.

[28]  J. Kwak‐Kim,et al.  Why are pregnant women susceptible to COVID-19? An immunological viewpoint , 2020, Journal of Reproductive Immunology.

[29]  R. Trimble.  COVID-19 Dashboard , 2020 .

[30]  Erik Schubach.  Seventy Two Hours , 2014 .

[31]  J. Sheffield,et al.  The Management of Respiratory Infections During Pregnancy , 2006, Immunology and Allergy Clinics of North America.

[32]  L. A. Wolfe,et al.  Effects of human pregnancy on the ventilatory chemoreflex response to carbon dioxide. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[33]  A. Gundlapalli,et al.  Adverse Pregnancy Outcomes, Maternal Complications, and Severe Illness Among US Delivery Hospitalizations With and Without a Coronavirus Disease 2019 (COVID-19) Diagnosis , 2021 .